Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10984155 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL8020771 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL5653145 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL9461372 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL3868770 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL2487690 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL9405814 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL1409996 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL1409670 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 | |
| SCHEMBL9321916 | 1.00 | CA1 (0.59) | CA1ACE2FFAR1FFAR4GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113403840-A | Acyl chloride grafted cellulose fabric with lasting hydrophobicity and wear resistance, and preparation and application thereof | 中科检测技术服务(广州)股份有限公司 | 2021-09-17 | — | — | CN | claimed |
| EP-1233057-B1 | STERILIZED MICROBIAL CELLS | MITSUBISHI RAYON CO (JP) | 2015-03-04 | — | — | EP | claimed |
| EP-1233057-A1 | STERILIZED MICROBIAL CELLS | Mitsubishi Rayon Co., Ltd. (JP) | 2002-08-21 | — | — | EP | claimed |
| CN-117904236-A | Method for producing nicotinamide mononucleotide | 三菱化学株式会社 | 2024-04-19 | — | — | CN | disclosed |
| EP-4317191-A1 | MODIFIED NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | Mitsubishi Chemical Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117187320-A | Method for producing nicotinamide mononucleotide | 三菱化学株式会社 | 2023-12-08 | — | — | CN | disclosed |
| US-20230332114-A1 | MODIFIED NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-19 | — | — | US | disclosed |
| CN-116113645-A | Modified nicotinamide riboside phosphate transferase | 三菱化学株式会社 | 2023-05-12 | — | — | CN | disclosed |
| WO-2022202952-A1 | MODIFIED NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | 三菱ケミカル株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022022448-A1 | NEURAMINIDASE INHIBITOR COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 广州市恒诺康医药科技有限公司 | 2022-02-03 | — | — | WO | disclosed |
| CN-113403840-A | Acyl chloride grafted cellulose fabric with lasting hydrophobicity and wear resistance, and preparation and application thereof | 中科检测技术服务(广州)股份有限公司 | 2021-09-17 | — | — | CN | disclosed |
| EP-1578214-B1 | FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL | DSM IP ASSETS BV (NL) | 2009-05-27 | — | — | EP | disclosed |
| EP-1811028-A1 | IMPROVED HYDROXYNITRILE LYASE | Mitsubishi Rayon Co., Ltd. (JP) | 2007-07-25 | — | — | EP | disclosed |
| US-20060286265-A1 | Food composition comprising a satiety enhancing amount of triacylglycerol and use in the manufature of a medicament for the treatment or prevention of obesity | DSM IP ASSETS B.V. (NL) | 2006-12-21 | — | — | US | disclosed |
| EP-1578214-A1 | FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL AND USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF OBESITY | LTP Lipid Technologies Provider AB (SE) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004057982-A1 | FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL AND USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF OBESITY | LTP LIPID TECHNOLOGIES PROVIDER AB (SE) | 2004-07-15 | — | — | WO | disclosed |
| EP-1233057-A1 | STERILIZED MICROBIAL CELLS | Mitsubishi Rayon Co., Ltd. (JP) | 2002-08-21 | — | — | EP | disclosed |
| US-4493843-A | Indole and indoline carboxylic acid compounds and method of use | MAY & BAKER LIMITED (GB) | 1985-01-15 | — | — | US | disclosed |
| EP-0042298-B1 | INDOLE AND INDOLINE DERIVATIVES | MAY & BAKER LIMITED (GB) | 1984-09-12 | — | — | EP | disclosed |
| EP-0042298-A1 | Indole and indoline derivatives | MAY & BAKER LIMITED (GB) | 1981-12-23 | — | — | EP | disclosed |